Self-antigen recognition by TGF beta1-deficient T cells causes their activation and systemic inflammation.
To investigate whether the multifocal inflammatory disease in TGFbeta1-deficient mice is caused by self-antigen (self-Ag)-specific autoreactive T cells, or whether it is caused by antigen independent, spontaneous hyperactivation of T cells, we have generated Tgfb1(-/-) and Tgfb1(-/-) Rag1(-/-) mice expressing the chicken OVA-specific TCR transgene (DO11.10). On a Rag1-sufficient background, Tgfb1(-/-) DO11.10 mice develop a milder inflammation than do Tgfb1(-/-) mice, and their T cells display a less activated phenotype. The lower level of activation correlates with the expression of hybrid TCR (transgenic TCRbeta and endogenous TCRalpha), which could recognize self-Ag and undergo activation. In the complete absence of self-Ag recognition (Tgfb1(-/-) DO11.10 Rag1(-/-) mice) inflammation and T-cell activation are eliminated, demonstrating that self-Ag recognition is required for the hyper-responsiveness of TGFbeta1-deficient T cells. Thus, TGFbeta1 is required for the prevention of autoimmune disease through its ability to control the activation of autoreactive T cells to self-Ag.
22 references, click to expand
-
Expression of dual TCR on DO11.10 T cells allows for ovalbumin-induced oral tolerance to prevent T cell-mediated colitis directed against unrelated enteric bacterial antigens.J Immunol. 2004 Feb 1;172(3):1515-23 PMID: 14734729
-
MHC-independent genetic regulation of liver damage in a mouse model of autoimmune hepatocellular injury.Lab Invest. 2005 Apr;85(4):550-61 PMID: 15696185
-
Transforming growth factor beta blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiation.J Exp Med. 2003 Jun 16;197(12):1689-99 PMID: 12810687
-
TGF-beta 1 regulates lymphocyte homeostasis by preventing activation and subsequent apoptosis of peripheral lymphocytes.J Immunol. 2003 May 1;170(9):4612-22 PMID: 12707339
-
TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes.J Immunol. 2003 Apr 1;170(7):3645-52 PMID: 12646629
-
Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice.Cancer Res. 2002 Nov 15;62(22):6362-6 PMID: 12438215
-
TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.J Clin Invest. 2002 Mar;109(6):787-96 PMID: 11901187
-
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.J Exp Med. 2000 Jul 17;192(2):303-10 PMID: 10899917
-
Requirement for transforming growth factor beta1 in controlling T cell apoptosis.J Exp Med. 2001 Aug 20;194(4):439-53 PMID: 11514601
-
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.J Exp Med. 2003 Dec 15;198(12):1875-86 PMID: 14676299
-
Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis.Cancer Res. 1999 Jul 15;59(14):3379-86 PMID: 10416598
-
Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction.Mol Cell Biol. 1999 Apr;19(4):2495-504 PMID: 10082515
-
Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta.EMBO J. 1999 Mar 1;18(5):1280-91 PMID: 10064594
-
Smad3 mutant mice develop metastatic colorectal cancer.Cell. 1998 Sep 18;94(6):703-14 PMID: 9753318
-
Germ-free and barrier-raised TGF beta 1-deficient mice have similar inflammatory lesions.Transgenic Res. 1997 May;6(3):197-202 PMID: 9167267
-
Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice.Am J Pathol. 1995 Jan;146(1):276-88 PMID: 7856734
-
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):770-4 PMID: 8421714
-
Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.Nature. 1992 Oct 22;359(6397):693-9 PMID: 1436033
-
CD28 disruption exacerbates inflammation in Tgf-beta1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-beta1.Blood. 2004 Jun 15;103(12):4594-601 PMID: 15016653
-
TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells.J Exp Med. 2005 Apr 4;201(7):1061-7 PMID: 15809351
-
Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGFbeta1-deficient mice.Cell Immunol. 2004 Nov-Dec;232(1-2):96-104 PMID: 15922720
-
Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.J Immunol. 2004 May 1;172(9):5149-53 PMID: 15100250
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
